News from regulus therapeutics inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 26, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus to Present at Cowen and Company 35th Annual Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 19, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus to Present at 2015 RBC Capital Markets' Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 18, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus Reports Fourth Quarter and Year-End 2014 Financial Results and Recent Highlights

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 12, 2015, 17:09 ET
Regulus Therapeutics Inc. Logo

Regulus Announces Timing for Fourth Quarter and Year-End 2014 Financial Results Webcast and Conference Call

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 09, 2015, 07:00 ET
Regulus Therapeutics Inc. Logo

All HCV Patients Treated with a Single SC Administration of 4 mg/kg of RG-101 Responded with Mean Viral Load Reduction of 4.8 log10 at Day 29 and 9/14 Patients are Below the Limit of Quantification at Day 57

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 02, 2015, 16:05 ET
Regulus Therapeutics Inc. Logo

Regulus to Present at Two Upcoming Investor Conferences

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Feb 02, 2015, 08:00 ET
Regulus Therapeutics Inc. Logo

Regulus Earns Milestone Payment from Biogen Idec Related to the Identification of Potential microRNA Biomarkers in Multiple Sclerosis

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced...

Jan 08, 2015, 08:00 ET

Regulus Announces Key Goals Under its 'Clinical Map Initiative' for 2015

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Nov 26, 2014, 16:05 ET

Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Nov 15, 2014, 18:00 ET
Nov 06, 2014, 16:05 ET

Regulus to Present at the Credit Suisse Healthcare Conference

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Nov 05, 2014, 16:05 ET

Regulus Reports Third Quarter 2014 Financial Results and Recent Highlights

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Nov 03, 2014, 16:05 ET

Regulus Announces Closing of Public Offering of $103.5M of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Oct 30, 2014, 16:05 ET

Regulus Announces Timing for Third Quarter 2014 Financial Results Webcast and Conference Call

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Oct 28, 2014, 20:10 ET

Regulus Announces Pricing of Public Offering of Common Stock

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company developing innovative medicines targeting microRNAs, today...

Oct 27, 2014, 16:00 ET

Regulus Announces Commencement of Public Offering of Common Stock

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company developing innovative medicines targeting microRNAs, today...

Oct 22, 2014, 07:30 ET
Oct 14, 2014, 08:00 ET

Regulus Presents New Preclinical Data on Multiple Programs and Provides Portfolio Overview at 10th Annual Oligonucleotide Therapeutics Society (OTS) Meeting

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Sep 24, 2014, 08:00 ET

Regulus Announces Notice of Allowance from U.S. Patent Office Related to microRNA-103/107 Program in Metabolic Disorders

 Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...

Sep 18, 2014, 08:00 ET

Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients

 Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting...